Results 251 to 260 of about 755,810 (388)

Matrix Metalloproteinase Hypothesis of Plaque Rupture

, 2001
Prediman K. Shah, Zorina S. Galis
openalex   +1 more source

Role of Histone Deacetylase and Inhibitors in Cardiovascular Diseases

Cell Proliferation, EarlyView.
HDACs play an important role in the occurrence and development of cardiovascular diseases, such as myocardial hypertrophy, hypertension, and atherosclerosis. HDAC inhibitors have broad prospects for the treatment of CVD, and different HDAC subtypes can act through different mechanisms.
Li‐Ying Zhang, Yue‐Yue Wang, Ri Wen, Tie‐Ning Zhang, Ni Yang   +4 more
wiley   +1 more source

The de Winter pattern in a single precordial lead caused by high-grade stenosis of the proximal left anterior descending artery with plaque rupture: A case report. [PDF]

Heliyon
Song Z, Huo Y, Wu Q, Yu X, Yang Y, Meng Z, Li X.   +6 more
europepmc   +1 more source

New insights into atherosclerotic plaque rupture

, 2001
Denise Braganza, Martin R. Bennett
openalex   +1 more source

Preventing plaque rupture [PDF]

Nature Reviews Drug Discovery, 2008
openaire   +2 more sources

Cardiac troponin at the point of care in acute and chronic coronary syndromes

Diabetes, Obesity and Metabolism, EarlyView.
Abstract High‐sensitivity cardiac troponin (hs‐cTn) assays are integral to the assessment of patients with acute chest pain where prompt and accurate diagnosis of myocardial infarction enables timely delivery of potentially life‐saving treatment. In the Emergency Department, implementation of central laboratory hs‐cTn assays has reduced length of stay ...
Michael McDermott, Yong Yong Tew, Jamie G. Cooper, Deepak Harry, Nicholas L. Mills   +4 more
wiley   +1 more source

Three-Dimensional Fluid Dynamical Features of Coronary Plaque Rupture Provoking Acute Coronary Syndrome. [PDF]

J Atheroscler Thromb, 2022
Iida K, Hiro T, Fukamachi D, Sudo M, Nishida T, Akutsu N, Murata N, Kogo T, Kojima K, Mineki T, Tamaki T, Migita S, Morikawa T, Okumura Y.   +13 more
europepmc   +1 more source

PCSK9 and coronary atherosclerosis progression beyond LDL‐cholesterol in coronary artery disease patients

European Journal of Clinical Investigation, EarlyView.
In a population of patients with stable CAD, circulating levels of PCSK9 are independently associated with the progression of adverse coronary plaque phenotypes, as assessed by serial coronary computed tomography angiography. At RNA‐seq analysis of whole blood, PCSK9 was linked to the expression of genes involved in the innate‐immune response.
Rosetta Ragusa, Silvia Rocchiccioli, Serena Del Turco, Antonio Morlando, Giuseppina Basta, Arthur Scholte, Danilo Neglia, Chiara Caselli   +7 more
wiley   +1 more source

Assessment of Residual Vasospasm in Patients with Plaque Rupture or Plaque Erosion using Optical Coherence Tomography. [PDF]

J Atheroscler Thromb
Sekimoto T, Mori H, Koba S, Arai T, Matsukawa N, Sakai R, Yokota Y, Sato S, Tanaka H, Masaki R, Oishi Y, Ogura K, Arai K, Nomura K, Sakai K, Tsujita H, Kondo S, Tsukamoto S, Suzuki H, Shinke T.   +19 more
europepmc   +1 more source

<i>APOL1</i> Genetic Variants Are Associated With Increased Risk of Coronary Atherosclerotic Plaque Rupture in the Black Population. [PDF]

Arterioscler Thromb Vasc Biol, 2021
Cornelissen A, Fuller DT, Fernandez R, Zhao X, Kutys R, Binns-Roemer E, Delsante M, Sakamoto A, Paek KH, Sato Y, Kawakami R, Mori M, Kawai K, Yoshida T, Latt KZ, Miller CL, de Vries PS, Kolodgie FD, Virmani R, Shin MK, Hoek M, Heymann J, Kopp JB, Rosenberg AZ, Davis HR, Guo L, Finn AV.   +26 more
europepmc   +1 more source